Thyrocare Technologies Ltd IPO (Thyrocare Technologies IPO) Detail

Apr 27, 2016 - Apr 29, 2016

Incorporated in 2000, Thyrocare Technologie Ltd is one of the leading pan-India diagnostic chains and conduct an array of medical diagnostic tests and profiles of tests that helps in early detection and management of disorders and diseases.

They are India's first fully automated diagnostic laboratory having its strong presence in more than 2000 cities / towns in India and internationally. As of November 30, 2015, they offered 192 tests and 54 profiles of tests to detect a number of disorders, including thyroid disorders, growth disorders, metabolism disorders, auto-immunity, diabetes, anemia, cardiovascular disorders, infertility and various infectious diseases.

Their laboratory process over 30,000 sample and above 1 lakh investigations every day. Their profiles of tests include 17 profiles of tests administered under their 'Aarogyam' brand. Through wholly owned subsidiary, NHL, they operate a network of molecular imaging centers in New Delhi, Navi Mumbai and Hyderabad, focused on early and effective cancer monitoring.

Company Promoters:

The promoters of the company are:

1. Dr A. Velumani
2. Mr A. Sundararaju

Company Financials:

Particulars	For the year/period ended (in Rs. Million)
	31-Dec-15	31-Mar-15
Total Revenue	1,804.73	1,903.38
Profit After Tax (PAT)	400.21	432.54

Objects of the Issue:

The object of the issue are to:

1. Achieve the benefits of listing the Equity Shares on the BSE and the NSE; and
2. Carry out the sale of up to 10,744,708 Equity Shares by the Selling Shareholders.

Thyrocare Technologies IPO Details

IPO Opening Date	Apr 27, 2016
IPO Closing Date	Apr 29, 2016
Issue Type	Book Built Issue IPO
Face Value	₹10 per equity share
IPO Price	₹420 to ₹446 per equity share
Market Lot	33 Shares
Min Order Quantity	33 Shares
Listing At	BSE, NSE
Issue Size	10,744,708 Eq Shares of ₹10 (aggregating up to ₹479.21 Cr)
Offer for Sale	10,744,708 Eq Shares of ₹10 (aggregating up to ₹[.] Cr)

Thyrocare Technologies IPO Lot Size

The Thyrocare Technologies IPO market lot size is 33 shares. A retail-individual investor can apply for up to 13 lots (429 shares or ₹191,334).

Application	Lots	Shares	Amount (Cut-off)
Minimum	1	33	₹14,718
Maximum	13	429	₹191,334

Thyrocare Technologies IPO Subscription Status (Bidding Detail)

The Thyrocare Technologies IPO is subscribed 73.55x times on Apr 29, 2016 23:15. The public issue subscribed 8.73x in the retail category, 73.18x in the QIB category, and 225.30x in the NII category. Check Day by Day Subscription Details (Live Status)

Category	IPO Subscription
QIB	73.18x
NII	225.30x
RII	8.73x
Total	73.55x

Thyrocare Technologies IPO Prospectus

Thyrocare Technologies IPO Rating

858

4.0

Rating:

Vote Here ...

Thyrocare Technologies IPO Listing Date

Listing Date	Monday, May 9, 2016
BSE Script Code	539871
NSE Symbol	THYROCARE
Listing In	B
ISIN	INE594H01019
IPO Price	₹446 per equity share
Face Value	₹10 per equity share

Listing Day Trading Information

.
IPO Price
Open
Low
High
Last Trade
Volume

BSE
₹446.00
₹662.00
₹606.00
₹665.40
₹618.10
2,678,027

NSE
₹446.00
₹665.00
₹605.80
₹665.00
₹618.80
12,860,078

Thyrocare Technologies IPO Reviews / Ratings

Ajcon Global Services Ltd - Subscribe
Dilip Davda - Subscribe
Hem Securities - Subscribe
SPA Financial Advisor Ltd - Subscribe
KR Choksey Securities Ltd - Subscribe
ABM Equity Research Ltd - Subscribe
GEPL Capital Ltd - Subscribe

Company Contact Information

Thyrocare Technologies Ltd
D/37-1, TTC Industrial Area
MIDC Turbhe,
Navi Mumbai 400 703

Phone: +(91 22) 2762 2762
Email: ramjee.d@thyrocare.com
Website: http://www.thyrocare.com

Thyrocare Technologies IPO Registrar

Link Intime India Private Ltd
   Link Intime India Private Ltd
   C 101, 247 Park, L.B.S.Marg,
   Vikhroli (West), Mumbai - 400083

Phone: +91-22-4918 6270
Email: ttl.ipo@linkintime.co.in
Website: http://www.linkintime.co.in

Thyrocare Technologies IPO Lead Manager(s)

Lead Manager Reports

Thyrocare Technologies IPO FAQs

What is Thyrocare Technologies IPO?

Thyrocare Technologies IPO is a main-board IPO of 10,744,708 equity shares of the face value of ₹10 aggregating up to ₹479.21 Crores. The issue is priced at ₹420 to ₹446 per equity share. The minimum order quantity is 33 Shares.

The IPO opens on Apr 27, 2016, and closes on Apr 29, 2016.

Link Intime India Private Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
When Thyrocare Technologies IPO will open?

The Thyrocare Technologies IPO opens on Apr 27, 2016 and closes on Apr 29, 2016.
What is the lot size of Thyrocare Technologies IPO?

Thyrocare Technologies IPO lot size is 33 Shares and the minimum order quantity is 33 Shares.
How to apply for Thyrocare Technologies IPO?

You can apply in Thyrocare Technologies IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.
When Thyrocare Technologies IPO allotment?

The finalization of Basis of Allotment for Thyrocare Technologies IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Thyrocare Technologies IPO allotment status.
When is Thyrocare Technologies IPO listing date?

The Thyrocare Technologies IPO listing date is on Monday, May 9, 2016.

Thyrocare Technologies IPO Message Board

Ranked Members

1737. Septa |Jun 27, 2016 20:36

IPO Guru (4000+ Posts, 4500+ Likes)

brought some more given more such company tapping the IPO market in near future

1737.1. Gravitas |Jun 28, 2016 12:38

Top Contributor (200+ Posts)

That''s a smart move. I missed adding some at 530/- level.

1736. Gravitas |Jun 13, 2016 03:29

Top Contributor (200+ Posts)

Thyrocare: FY16 results: Top-line up 25%, PBT up 21%, they paid much higher taxes this year & therefore Net Profit up only 15%. There was fresh equity infusion this year (IPO) leading to lower growth in EPS (10% only).

Thyrocare is debt-free, cost-focused &, tech-savvy (no material technology ''disruption'' threat is there IMO). DIY Kits are a threat but not a major one. They can give a quick estimate of blood sugar alright but can''t profile serum,thyroid, lipid etc.

Only thing that I''m worried from the start is its very rich valuation- currently 59-60 PE. Don''t know how long it can sustain such high PE based on 10%-15% eps/profit growth rates.

Some one on this board says that it''s a fraud company rigging books & looting customers!!?? I don''t know about any impending fraud but at least it''s not looting customers. It''s service is very cheap & results very accurate.

The Company doesn''t seem bad..it'' price could be. Anyways, I''m hanging on to it.

P.S. The market is factoring almost ''nil'' probability of Fed Funds Rate hike in June. It''s most likely now in December 2016. Brexit is also not expected to affect Indian markets in a big way. Passage of GST in Monsoon Session will be a shot in the arm.
The only near term risk to market is less than expected Monsoon.

1736.1. shareipo |Jun 20, 2016 13:54

whats happening in this stock ?

1736.2. Gravitas |Jun 20, 2016 15:52

Top Contributor (200+ Posts)

There was good growth registered in FY16 but not strong enough to prop the high valuation multiples. Promoters r expecting 30% top-line growth in current year whereas EPS growth should be around 20%...

1735. Eagleye |Jun 12, 2016 11:20

IPO Guru (5700+ Posts, 19000+ Likes)

Thyrocare Technologies Ltd

EPS FY15-16 = Rs.10.06 (consolidated & diluted)

http://www.bseindia.com/xml-data/corpfiling/AttachLive/FFBACB36_65A4_4BE7_967E_E7DD532B76A2_181158.pdf

Thyrocare Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 11, 2016, inter alia, have recommended a payment of final dividend of Rs. 2.50 (Rupees Two and Paise Fifty only) per equity share of the face value of Rs. 10 each for the financial year ended March 31, 2016. The Company has declared two interim dividends. These two interim dividends constitutes a total payout of Rs. 7.50 per equity share (75% on the face value of Rs. 10/- each) for the financial year 2015-2016. The Total dividend for the year including the final dividend (subject to the approval of the shareholders at the ensuing Annual General Meeting) will be Rs. 10/- (Rupees Ten only) per equity share.

1735.1. Djaghera |Jun 12, 2016 13:49

According to you, should we hold thyrocare allotments or exit early as possible ??

1735.2. gamble |Jun 12, 2016 21:34

IPO Guru (1600+ Posts, 3900+ Likes)

I don''t think..hold is very good idea..ipo investor should take some profit out.

1734. Samim Ahammad |Jun 11, 2016 21:07

1733. Khemka |Jun 6, 2016 18:26

IPO Guru (1000+ Posts, 400+ Likes)

Thyrocare down to 590 as allegation on company of doing fraud with setting with doctors in looting customers with various types of unnecessary deceased

1733.1. acestocktip |Jun 6, 2016 22:37

Ex Spurts of the forum RKS was foul mouthing me,this is not a news to me,This company practices unethical means,even financial numbers are rigged.More skeletons to tumble,even if this stock goes up ( to trap retailers,CC ppl may do this gimmick), its wise to exit this stock,by diwali this stock to trade below IPO, fair value not more than 300,maybe 300 is also too much.

1732. acestocktip |Jun 6, 2016 12:50

665-668 is the level,one must look into, Unless stock closes above 665-668, this stock will not give any major gains,every rally is being sold into.

Yes,funny things happen in stock market,so for those who are looking at other side of green ( red in this case), 665-668 is level one must look out for,any major follow up move will come if stock manages to close above 665-668. For us this stock will be relegated to JUNK STATUS in coming months.Like Indigo, management will reveal some uneasy facts.As it is diagnostic business got no STRONG MOAT easier to replicate the business,is vulnerable to tech disruption viz in form of DIY kits.

STRONG SELL ON RISE.. and if it closes abov 665-668, have some fun while CC ( company circle) jack up price only to bring it down later on.

1731. acestocktip |Jun 6, 2016 12:36

Update : Thyrocare, under performing ,we have had given SELL ON RISE call,re-iterating stock will be below Issue price in next 4-5 months ( by diwali).

Markets are up by 15% but Thyorcare is trading below the listing day high, gave two exit opportunities.

Update on thyrocare : We have had given SELL ON RISE call.ON listing day,recommended to sell alloted stocks.Some ppl were misguided by septic,oneeyed and Rag picker kaput S hit ( RKS) & people bought stock at higher price 650+. We were spot on when we said that stock will give an opportunity ( sucker''''s rally) to exit, stock is back to 605,

Road ahead - Break below 595,two consecutive close below 595 will take Thyrocare below 480,we expect one Lower Circuit in this counter if Global market turns jittery on prospect of FED RATE HIKE.Be very careful with this stock.EXIT,this stock is not even worth 300.

OUR PRICE TARGET by DIWALI .. BELOW IPO PRICE

1730. Dj |Jun 3, 2016 12:47

Does someone know when Thyrocare is going to publish it''s quarterly result ??? If so plz provide the date...

1729. GURDEEP SINGH |May 31, 2016 13:03

Keep Fund Ready for 4 Good IPO coming Between 16 June to 10 July
1.Mahanagar Gas
2.L&T Infotech
3.RBL
4.Advanced Enzyme Tech

1729.1. Eagleye |May 31, 2016 13:10

IPO Guru (5700+ Posts, 19000+ Likes)

what about "Quess Corp" ?

1729.2. Eagleye |May 31, 2016 13:11

IPO Guru (5700+ Posts, 19000+ Likes)

RBL ka SEBI approval is still awaited

1728. Antonio Munia |May 27, 2016 19:33

Will Kranti Industries IPO open on Monday ?

1727. Manoj budhwani |May 27, 2016 01:36

Hi eagleye.. I do follow ur views and suggestions on regular basis.. Once u told that u will hold thyrocare upto 700/- or 31st may whichever earlier. Can you discuss what should be advisable ? To hold or book profit? Septa sir your views also on this.

1727.1. Eagleye |May 27, 2016 23:56

IPO Guru (5700+ Posts, 19000+ Likes)

I will sell on 31st May

1726. Dj |May 26, 2016 17:13

Does anyone know throcare''s result date ???

1725. Happy Investing |May 23, 2016 13:07

WHEN IS THE Q4 RESULT DATE?

1724. acestocktip |May 19, 2016 18:10

Update on thyrocare : We have had given SELL ON RISE call.ON listing day,recommended to sell alloted stocks.Some ppl were misguided by septic,oneeyed and Rag picker kaput S hit ( RKS) & people bought stock at higher price 650+. We were spot on when we said that stock will give an opportunity ( sucker''s rally) to exit, stock is back to 605,

Road ahead - Break below 595,two consecutive close below 595 will take Thyrocare below 480,we expect one Lower Circuit in this counter if Global market turns jittery on prospect of FED RATE HIKE.Be very careful with this stock.EXIT,this stock is not even worth 300.

OUR PRICE TARGET by DIWALI .. BELOW IPO PRICE

1724.1. Indy |May 19, 2016 22:10

EXCELLENT keep it up
One rotten fish spoil the whole pond

1724.2. Indy |May 25, 2016 02:43

What u suggest on Ujjivan
Holding 15000 shares@257

1723. Malav Raval |May 17, 2016 11:39

By thyrocare around 630 with Target 637, 642, 648. SL 625

1722. IPO Ka Gyani |May 14, 2016 12:13

Everybody here is talking about Ujjivan. But I think Thyrocare will show huge run up in a day or two. Just being accumulated by operator. Huge upside expected.

Load more comments (2 replies)

1722.3. CHD |May 16, 2016 11:13

IPO Guru (1100+ Posts, 400+ Likes)

yahan bade bade gyani bhi dhara shai ho jaate hain .... ye market hai , bhai ....!

1722.4. venki |May 17, 2016 14:44

bhai, teen din hogaya aap ee bataake... kuch hila nahi......

1721. Ramraj gupta |May 13, 2016 23:01

Buy at current level

1720. Malav Raval |May 13, 2016 12:56

692 ki Train nikal jaye iske pehle 630 me enter ho jao, bahut jald 692 ka station aane vala hai. SL 580 which will not heat.

Time period: Max 8-10 trading sessions.

1719. Shivajee |May 12, 2016 23:10

IPO Mentor (700+ Posts, 100+ Likes)

I am holding Thyrocare at 650 levels. It went down below 600, but now its around 630. I m not going to sell it before 700. I am planning to add more at 610-615 range

Load more comments (5 replies)

1719.6. CHD |May 16, 2016 11:20

IPO Guru (1100+ Posts, 400+ Likes)

Market follows no rules .... it does what it does....!

1719.7. Shivajee |May 20, 2016 10:06

IPO Mentor (700+ Posts, 100+ Likes)

RKS sir,

You told not to average @627. I followed your advice. You were very right, now its around 606. Thanks for you advising me not to buy at that price. I feel I can buy some at 600 mark.

1718. Indy |May 12, 2016 17:25

Highest return stock will b ujjivan multibagger MULTIBAGGER. MULTIBAGGER
BLACK HORSE. Among the three newly listed shares

1718.1. Shivajee |May 12, 2016 23:24

IPO Mentor (700+ Posts, 100+ Likes)

how/. who said

1718.2. CHD |May 16, 2016 11:21

IPO Guru (1100+ Posts, 400+ Likes)

Ujji crossed 258 today , indeed ...!

Check Messages by Ranked Members

Find Thyrocare Technologies IPO Latest Update

Useful Articles

Name		Phone
Email		City
State
Are you a day trader?